Biohaven Ltd. (BHVN)
NYSE: BHVN · Real-Time Price · USD
13.50
-0.64 (-4.53%)
Aug 20, 2026, 4:00 PM EDT - Market closed
Biohaven Market Cap
Biohaven has a market cap or net worth of $2.04 billion as of August 20, 2026. Its market cap has increased by 26.39% in one year.
Market Cap
2.04B
Enterprise Value
2.07B
1-Year Change
26.39%
Ranking
Category
Stock Price
$13.50
ChartMarket Cap Chart
Since September 23, 2022, Biohaven's market cap has increased from $261.58M to $2.04B, an increase of 679.54%. That is a compound annual growth rate of 69.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2026 | 2.04B | 36.12% |
| Dec 31, 2025 | 1.50B | -60.34% |
| Dec 31, 2024 | 3.78B | 9.99% |
| Dec 29, 2023 | 3.43B | 262.97% |
| Dec 30, 2022 | 946.07M | 261.68% |
| Sep 23, 2022 | 261.58M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Maravai LifeSciences Holdings | 2.15B |
| Zenas BioPharma | 2.06B |
| Palvella Therapeutics | 2.05B |
| Generate Biomedicines | 2.05B |
| Sarepta Therapeutics | 2.03B |
| Stoke Therapeutics | 2.03B |
| Agios Pharmaceuticals | 2.01B |
| Xencor | 2.01B |